ESMO Asia is an annual gathering focused on multidisciplinary oncology in the Asian region.
ESMO Asia provides exhibitors and guests with a unique opportunity to explore cutting edge science, as well as groundbreaking therapies and innovative practices that will undoubtedly shape the oncology field going forward.
Taking place in Singapore, congress attendees can expect a diverse and exciting programme, including plenary sessions, opportunities to “Meet The Expert”, and most importantly, plenty of networking opportunities. By attending ESMO Asia, you will gain insight into exciting clinical developments and get the chance to have powerful discussions with some of the leaders in the field of oncology.
ESMO Asia will welcome speakers and experts from all oncology disciplines, with the aim of creating the right atmosphere for further collaboration.
Save the date and be part of a conference that promises to be transformative in terms of discussing new research and treatment options.
Come and say hello to the Paxman team, who will be stationed at booth B404 this year. The team will once again be exhibiting the Paxman Scalp Cooling System (PSCS) and they’ll be on hand to offer information and support on all things scalp cooling, including quick and easy summaries of the latest scalp cooling data.
Book a meeting with the Paxman team here.
There will be a number of abstracts available on scalp cooling and chemotherapy-induced peripheral neuropathy (CIPN) during the event.
Title: First Real-World Evidence Comparing EVA, an Indigenous Made-in-India Scalp Cooling System, with Paxman for Chemotherapy-Induced Alopecia in Cancer Patients. Data from cancer center India.
Lead Author: Amish D. Vora
Abstract number: 865P
Date: Friday December 5th
Title: Prevalence and Risk Factors of Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Patients: Insights from an Indian Tertiary Care Center
Lead Author: Maheboob Hussain Shaik
Abstract number: 873eP (on demand)
Date: Friday December 5th
Title: Factors associated with taxane-induced neuropathy in non stage IV female breast cancer patients treated at a tertiary care hospital, Karachi, Pakistan.
Lead Author: Bakhtawar Masood
Abstract number: 37P
Date: Friday December 5th
Explore the full programme on the ESMO website.
Head of International Sales
Regional Manager LATAM & ASEAN
CEO
